Atria Investments Inc Sells 29,074 Shares of Colgate-Palmolive Company $CL

Atria Investments Inc cut its holdings in Colgate-Palmolive Company (NYSE:CL) by 53.6% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 25,153 shares of the company’s stock after selling 29,074 shares during the period. Atria Investments Inc’s holdings in Colgate-Palmolive were worth $2,011,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. ProShare Advisors LLC raised its position in Colgate-Palmolive by 11.0% during the third quarter. ProShare Advisors LLC now owns 2,047,542 shares of the company’s stock valued at $163,681,000 after purchasing an additional 202,379 shares in the last quarter. Providence Capital Advisors LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter valued at about $5,373,000. Asset Management One Co. Ltd. lifted its position in Colgate-Palmolive by 3.9% in the 3rd quarter. Asset Management One Co. Ltd. now owns 422,292 shares of the company’s stock worth $33,758,000 after buying an additional 16,017 shares during the last quarter. Vanguard Group Inc. boosted its stake in Colgate-Palmolive by 1.2% in the second quarter. Vanguard Group Inc. now owns 82,751,689 shares of the company’s stock worth $7,522,129,000 after buying an additional 993,432 shares in the last quarter. Finally, TD Waterhouse Canada Inc. grew its position in Colgate-Palmolive by 248.5% during the third quarter. TD Waterhouse Canada Inc. now owns 87,410 shares of the company’s stock valued at $6,909,000 after acquiring an additional 62,327 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.

Insider Activity at Colgate-Palmolive

In related news, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the sale, the insider directly owned 17,645 shares of the company’s stock, valued at $1,663,041.25. This represents a 54.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Stanley J. Sutula III sold 97,843 shares of the firm’s stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the transaction, the chief financial officer directly owned 55,310 shares of the company’s stock, valued at $5,214,073.70. This represents a 63.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 184,683 shares of company stock valued at $17,486,693. 0.41% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $95.57 on Wednesday. The business has a 50 day moving average of $84.59 and a 200 day moving average of $82.01. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The company has a market cap of $77.04 billion, a PE ratio of 36.48, a P/E/G ratio of 4.36 and a beta of 0.29. The company has a quick ratio of 0.27, a current ratio of 0.42 and a debt-to-equity ratio of 5.90.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the previous year, the firm earned $0.91 EPS. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. As a group, equities research analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 13th. Investors of record on Wednesday, January 21st were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 79.39%.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the stock. Wells Fargo & Company upped their price objective on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the company an “equal weight” rating in a research note on Sunday, February 1st. Rothschild & Co Redburn set a $93.00 price target on shares of Colgate-Palmolive in a research note on Friday. Evercore raised their price objective on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a research note on Monday, February 2nd. Piper Sandler increased their target price on Colgate-Palmolive from $88.00 to $96.00 and gave the company an “overweight” rating in a report on Friday, January 30th. Finally, Barclays raised their price target on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 3rd. Eleven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $94.38.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.